The strategic shift from logistics to traditional Chinese medicine (TCM) business marks an extension and upgrade of the Group’s industrial chain. It is expected to lift the Company’s market valuation and investment appeal in Hong Kong’s capital market, and set a benchmark for other Hong Kong-listed TCM enterprises pursuing business expansion and industrial chain integration.
With continuous investment and in-depth cultivation, The Le’s Group actively explores the modernisation and industrialisation of TCM. This transformation will help improve the overall market image of the TCM sector on HKEX and attract more capital and investors to the TCM track.
The reorganisation also injects new growth momentum into the TCM medical service segment under the Group’s Hong Kong listed platform. It will draw sustained capital interest in TCM healthcare investment opportunities and serve as a model for peer TCM medical service providers seeking access to capital markets.